Development of human antibody mice
Updated time: 2020-08-21 17:54:53
Development of human antibody mice
Docket Number
10T-1090709
Announcement Date
2020-08-21
IP Status
Know-how
Abstract
We obtained various sequential segments (100 - 300 kb) of human antibody genes with the CRISPR system, and then subcloned each of them into YACs. Those segments were reconstructed in yeast. Afterward, the yeast containing human antibody genes were fused with mouse ES cell, to replace original mouse antibody genes with human antibody genes by homologous recombination.
Technological Advantages
- Any facility in Asia has been yet to publish the human-antibody mouse.
- Less time-consuming and reduce the humanization cost and affinity maturation.
- Directly undergoing human antibody in vivo selection and maturation in a transgenic mouse.
Applications of Technology
- If human-antibody mouse was generated successfully, we would proceed international material authorization.
- Development of new antibody-drug on our own.
- A platform for antibody drugs development cooperation with industry or academia, to obtain cancer-targeting therapeutic antibody and to early access the opportunity of novel drug development for cancer therapy.
Inventor
Han-Chung Wu etc.
Contact person
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office
Download Files

Development of human antibody mice